Bergmann, Karl-Christian
Straff, Wolfgang
Mücke, Hans-Guido
Stevanovic, Katarina
Zuberbier, Torsten
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 24 March 2025
Accepted: 8 April 2025
First Online: 2 June 2025
Conflict of interest
: K.-C. Bergmann is Chairman of the Board of the German Pollen Information Service Foundation. W. Straff is Head of the Department of Environmental Medicine and Health Assessment at the Federal Environment Agency. H.-G. Mücke is a research associate in the Department of Environmental Medicine and Health Assessment at the Federal Environment Agency and head of the Cooperation Center for Air Quality Monitoring and Air Pollution Control. K. Stevanovic declares that he has no conflict of interest with the content of the publication. T. Zuberbier has received lecture fees from Amgen, AstraZeneca, AbbVie, ALK-Abelló, Almirall, Astellas, Bayer Health Care, Bencard, Berlin Chemie, FAES Farma, HAL Allergie GmbH, Henkel, Kryolan, Leti, L’Oreal, Meda, Menarini, Merck Sharp & Dohme, Novartis, Nuocor, Pfizer, Sanofi, Stallergenes, Takeda, Teva, UCB, and Uriach; and industry consulting fees from Abivax, Almirall, Blueprint, Celldex, Celltrion, Novartis, and Sanofi. Unpaid memberships in organizations: “Allergic Rhinitis and its Impact on Asthma” (ARIA), Board Member, German Society for Allergology and Clinical Immunology (DGAKI), Head, European Centre for Allergy Research Foundation (ECARF), President, Global Allergy and Asthma Excellence Network (GA2LEN), and Member, Committee on Allergy Diagnosis and Molecular Allergology, World Allergy Organization (WAO).